CP-EPS8-NLS
Product Specifications
Target
Complement System
Related Pathways
Immunology/Inflammation
Bioactivity
CP-EPS8-NLS is a peptide with anti-AML properties. It disrupts ESP8-related signaling and exhibits anti-AML activity across various AML cell types. Additionally, CP-EPS8-NLS demonstrates potent antitumor effects in xenograft tumor models. It effectively downregulates EPS8 expression along with its downstream pathways.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS167038-01 48 Well
Human Mammalian Target of Rapamycin (mTOR) ELISA Kit
Sign In for Pricing
View Details MBS167038-02 96 Well
Human Mammalian Target of Rapamycin (mTOR) ELISA Kit
Sign In for Pricing
View Details